ACET Adicet: Forvard P/S multiplikatori
GURU.Markets terminali Adicet Bio (ACET) uchun prognoz qilingan P/S koeffitsiyenti grafigini namoyish etmoqda, bunda ko'rsatkich darajasi 10.80 ni tashkil etadi. Ushbu narx harakati avtoimmun patologiyalar terapiyasiga qaratilgan strategik biznes yo'nalishining o'zgarishini aks ettiradi. Bozor ishonchi rahbariyatning nufuzli ilmiy tajribasi va FDA hisobotlarining shaffofligi bilan mustahkamlanmoqda. Yuqori masshtablashish salohiyati va har bir dozaning past ishlab chiqarish xarajatlari aktivning global o'sish istiqbollarini tasdiqlaydi.
adicetbio.com (ACET) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Adicet Bio|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Adicet Bio, Inc.|ACET - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Adicet Bio, Inc.|ACET - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli majburiyatlari Adicet Bio|Tezkor likvidlik koeffitsiyenti adicetbio.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ACET - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda Adicet Bio|ACET - Biznesning o‘zini qoplash muddati|Kelajakdagi narxning foydaga nisbati Adicet Bio, Inc.|ACET - O‘sish sur’atiga tuzatilgan narx-foyda|EV/EBITDA multiplikatori Adicet Bio, Inc.|ACET - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Adicet Bio|ACET - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi adicetbio.com|ACET - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Adicet Bio
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Adicet (ACET)
Forward P/S ko'rsatkichi kutilayotgan savdo hajmi bilan nisbatan bozor qiymati dinamikasini o'lchaydi, bu esa savdo hajmlari tasdiqlamasiz aksiyalar talabining barqarorligini baholash imkonini beradi. GURU.Markets platformasida forward P/S metrikasini tahlil qilish orqali investor Adicet Bio (ACET) kompaniyasining avtomatlashtirilgan T-hujayralar terapiyasi ishlab chiqarishiga o'tish davridagi aktivlarning haddan tashqari qimmat baholanishi xavfini aniqlaydi, bunda qo'lda tayyorlanadigan muhitning ifloslanishini bartaraf etish kelgusi daromadga bevosita ta'sir ko'rsatadi.
Raqobatdosh kompaniyalar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|PTGX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|KNSA (Kiniksa) - Forvard P/S multiplikatori|Grifols SA (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ADPT|Forvard narx/daromad multiplikatori Celldex Corp CLDX|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com (BCRX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Dianthus Therapeutics Inc - Narxning kutilayotgan daromadga nisbati|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp - Sotuvga nisbatan forvard narx|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati PGEN|Forvard P/S multiplikatori PHAR|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Nektar Therapeutics Inc|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Immunome, Inc. - Forvard P/S multiplikatori|GOSS - Forvard P/S multiplikatori|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Savara Pharma SVRA|Forvard narx/daromad multiplikatori RIGL (Rigel Pharmaceuticals)|Narxning kutilayotgan daromadga nisbati ANAB|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|ENGN (enGene Holdings Inc) - Kelajakdagi narxning daromadga nisbati|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx JBIO (Aerovate Therapeutics Inc)|ACRS: Forvard P/S multiplikatori|kyvernatx.com (KYTX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|CABA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Forvard narx/daromad multiplikatori Theratechnologies, Inc THTX|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|Forvard P/S multiplikatori eledon.com ELDN|AGEN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio Inc.)|ZURA: Forvard P/S multiplikatori|ATYR - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Forvard narx/daromad multiplikatori Ikena Oncology, Inc. (IMA)|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|Forvard narx/daromad multiplikatori equilliumbio.com EQ|Connect Biopharma Holdings Limited - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|IFRX (InflaRx N.V.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XFOR: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Celularity (CELU)|INMB (INmune Bio Corp) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Barinthus Biotherapeutics Corp|Forvard P/S multiplikatori KZR|sabbiotherapeutics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp - Forvard P/S multiplikatori|GeoVax Corp (GOVX) - Forvard narx/daromad multiplikatori|EDSA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati ibioinc.com (IBIO)|Forvard narx/daromad multiplikatori CARM|XTLB (XTL Biopharmaceuticals Ltd) - Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori BOLT (Bolt Biotherapeutics)|HCWB (hcwbiologics.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Narxning prognoz qilingan daromadga nisbati|Aditxt Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Inc GRI|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vyome Therapeutics (HIND)|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Forvard P/S multiplikatori indaptusrx.com|Forvard P/S multiplikatori SCNI|Forvard narx/daromad multiplikatori calcimedica.com CALI|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|HOOK: Forvard narx/daromad multiplikatori|IGM Biosciences, Inc. - Narxning kutilayotgan daromadga nisbati|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|THRD: Sotuvga nisbatan forvard narx
